Market Overview

UPDATE: Morgan Stanley Raises PT to $35 on Paychex on Organic Growth Outlook

Share:
Related PAYX
10 Stocks That Rallied Four Days, Then Sold Off Yesterday
10 Notable Stocks Trading Ex-Dividend Friday, October 28
Are The Markets Heading For A World Of Pain In 2017? (Seeking Alpha)

Morgan Stanley reiterated its Neutral rating on Paychex (NASDAQ: PAYX) but raised its price target from $32 to $35.

Morgan Stanley commented, "We are positive on the payroll processing sector but see less upside for PAYX due to (1) weaker cycle to cycle earnings improvement, (2) less-attractive capital allocation, and (3) slow recovery for SMB clients coming out of the downturn. … Our estimates are unchanged from our previous publishing but we increase our multiple from 19.5X as our organic growth analysis still shows nearly 20pp improvement over the previous employment cycle"

Paychex closed at $33.37 on Thursday.

Latest Ratings for PAYX

DateFirmActionFromTo
Oct 2016JefferiesMaintainsUnderperform
Sep 2016CitigroupMaintainsSell
Sep 2016WedbushInitiates Coverage onNeutral

View More Analyst Ratings for PAYX
View the Latest Analyst Ratings

Posted-In: Morgan StanleyAnalyst Color Price Target Pre-Market Outlook Analyst Ratings

 

Related Articles (PAYX)

View Comments and Join the Discussion!